Texas 2015 - 84th Regular

Texas Senate Bill SB577 Latest Draft

Bill / Introduced Version Filed 02/13/2015

Download
.pdf .doc .html
                            84R7368 NC-F
 By: Perry S.B. No. 577


 A BILL TO BE ENTITLED
 AN ACT
 relating to the practice of therapeutic optometry.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Sections 351.358(b), (c), (d), and (e),
 Occupations Code, are amended to read as follows:
 (b)  A therapeutic optometrist may:
 (1)  administer, perform, or prescribe ophthalmic
 devices, procedures, and appropriate medications administered by
 topical or oral means[, in accordance with this section and Section
 351.3581,] to diagnose or treat visual defects, abnormal
 conditions, or diseases of the human vision system, including the
 eye and adnexa; or
 (2)  administer medication by parenteral means for a
 purpose and in a manner prescribed by Subsection (d) [(e)].
 (c)  A therapeutic optometrist may administer or prescribe
 oral analgesics [medications] only in the following
 classifications of oral pharmaceuticals:
 (1)  [one 10-day supply of oral antibiotics;
 [(2)  one 72-hour supply of oral antihistamines;
 [(3)     one seven-day supply of oral nonsteroidal
 anti-inflammatories;
 [(4)]  one three-day supply of any analgesic classified
 as a controlled substance under Schedule [identified in Schedules]
 III, IV, or [and] V of 21 U.S.C. Section 812; and
 (2)  one three-day supply of hydrocodone or of a
 hydrocodone combination product classified as a controlled
 substance under Schedule II of 21 U.S.C. Section 812
 [(5)     any other oral pharmaceutical recommended by the
 Optometric Health Care Advisory Committee and approved by the board
 and the Texas State Board of Medical Examiners].
 (d)  [A therapeutic optometrist may independently administer
 oral carbonic anhydrase inhibitors for emergency purposes only and
 shall immediately refer the patient to an ophthalmologist.
 [(e)]  A therapeutic optometrist may inject appropriate
 medication for a patient who has an anaphylactic reaction to
 counteract the anaphylaxis. The therapeutic optometrist shall
 immediately refer the patient to a physician.
 SECTION 2.  Section 351.3581, Occupations Code, is amended
 to read as follows:
 Sec. 351.3581.  [DIAGNOSIS AND] TREATMENT OF GLAUCOMA.
 [(a)] A therapeutic optometrist may not administer or prescribe an
 oral or parenteral medication or treat glaucoma unless the
 therapeutic optometrist holds a certificate issued by the board. A
 therapeutic optometrist certified under this section [subsection]
 shall be known as an optometric glaucoma specialist. To obtain a
 certificate, a therapeutic optometrist must [as required under
 Section 351.165(c)]:
 (1)  complete an instructional clinical review course;
 and
 (2)  pass an examination approved by the board.
 [(b)     Not later than the 30th day after the date of the
 initial diagnosis of glaucoma, a therapeutic optometrist shall
 engage in consultation with an ophthalmologist to develop an
 individual treatment plan that is approved by the therapeutic
 optometrist and ophthalmologist. The parameters of the
 consultation shall be at the discretion of the ophthalmologist but
 must at least include confirmation of the diagnosis and a plan for
 comanagement of the patient, including periodic review of the
 patient's progress.
 [(c)     A therapeutic optometrist required to engage in
 comanagement consultation with an ophthalmologist shall inform the
 patient diagnosed with glaucoma that the therapeutic optometrist is
 required to have the diagnosis confirmed and comanaged with an
 ophthalmologist of the patient's choosing or, if the patient does
 not choose an ophthalmologist, an ophthalmologist practicing in the
 geographic area in which the therapeutic optometrist practices.
 [(d)     A therapeutic optometrist shall refer a patient to an
 ophthalmologist if:
 [(1)     the patient is younger than 16 years of age and
 has been diagnosed as having glaucoma;
 [(2)     the patient has been diagnosed as having acute
 closed angle glaucoma;
 [(3)     the patient has been diagnosed as having
 malignant glaucoma or neovascular glaucoma;
 [(4)     the therapeutic optometrist determines that a
 patient's glaucoma is caused by a diabetic complication and, after
 joint consultation with the physician treating the diabetes and an
 ophthalmologist by telephone, fax, or another method, the physician
 or ophthalmologist determines that the patient should be seen by
 the physician or ophthalmologist; or
 [(5)     the therapeutic optometrist determines that a
 patient's glaucoma is not responding appropriately to a treatment
 specified in Subsection (f) and, after consulting a physician by
 telephone, fax, or another method, the physician determines that
 the patient should be seen by the physician or an appropriate
 specialist.
 [(e)     A therapeutic optometrist who refers a patient to a
 physician or specialist shall inform the patient that the patient
 may go to any physician or specialist the patient chooses. This
 subsection does not prevent a therapeutic optometrist from
 recommending a physician or specialist.
 [(f)     On making an initial diagnosis of glaucoma, a
 therapeutic optometrist shall set a target pressure that is not
 more than 80 percent of the initial intraocular pressure. The
 patient's glaucoma is not considered to be appropriately responding
 to treatment if the patient fails to achieve the target pressure
 within an appropriate time.
 [(g)     Before a therapeutic optometrist may prescribe a beta
 blocker, the therapeutic optometrist must take a complete case
 history of the patient and determine whether the patient has had a
 physical examination within the 180 days preceding the date of
 taking the history. If the patient has not had a physical
 examination or if the patient has a history of congestive heart
 failure, bradycardia, heart block, asthma, or chronic obstructive
 pulmonary disease, the therapeutic optometrist must refer the
 patient to a physician for a physical examination before initiating
 beta blocker therapy.
 [(h)     A therapeutic optometrist who diagnoses acute closed
 angle glaucoma may initiate appropriate emergency treatment for a
 patient but shall refer the patient to a physician in a timely
 manner.
 [(i)     A physician may charge a reasonable consultation fee
 for a consultation given as provided by this section.
 [(j)     A physician to whom a patient is referred by a
 therapeutic optometrist under this section shall forward to the
 therapeutic optometrist, not later than the 30th day after first
 seeing the patient, a written report on the results of the referral.
 The therapeutic optometrist shall maintain the report in the
 patient's records. A physician who, for a medically appropriate
 reason, does not return a patient to the therapeutic optometrist
 who referred the patient shall state in the physician's report to
 the therapeutic optometrist the specific medical reason for failing
 to return the patient.]
 SECTION 3.  This Act takes effect September 1, 2015.